Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 26

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 3
Chunk 26
---
 of
Directors

All of our directors receive annual fees and per-meeting fees
for their service on our board and its committees, in the following amounts:

  Annual fees in an amount of approximately $24,000 for directors classified as experts; and  

  Per-meeting fees in an amount of approximately $1,300 for directors classified as experts; 60% of such amounts for participation  

Such amounts are within the range for cash compensation for
external and unaffiliated directors of a company of our size (based on level of shareholders’ equity) under the Companies Law.

Cash Compensation of
Chairperson of the Board

In accordance with shareholders’ approval from August
2021, a chairperson of the board who is determined by the Board to be an “active chairperson” in light of increased involvement
in our activities and increased time investment in the performance of the duties accompanying the chairperson’s position compared
to the other directors, shall be entitled to increased compensation relative to our other directors of approximately $6,600 per month.
Our Board has determined that Mr. Nir Nimrodi, our chairperson of the board, is an active chairperson, and accordingly his fees as active
chairperson is as aforesaid.

Equity Compensation of
Directors

In accordance with our shareholders’ approval from August
2021, and in compliance with our compensation policy, each non-employee director is granted options to purchase 18,000 ordinary shares
of the Company on the date of our annual general shareholders meeting at which such director is elected or re-elected to the board. The
chairperson of our board is granted options to purchase 36,000 ordinary shares. These options vest over a period of one year, with 25%
of the options vesting at the end of each successive three-month period following the director’s appointment or re-appointment (as
applicable) by the general meeting of shareholders, subject to continued service through each vesting date. In the case of a director
who is elected to the Board for the first time, all of the options to purchase 18,000 ordinary shares shall vest following a one year
“cliff” - i. e., on the anniversary of the initial date of election.

All option grants to directors following the approval of our 2021
Share Incentive Plan by our shareholders (i. e., as of August 10, 2021), are subject to the terms of our 2021 Share Incentive Plan